These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37169497)

  • 1. Factors associated with viral load non-suppression in people living with HIV on ART in Nigeria: cross-sectional analysis from 2017 to 2021.
    Tomescu S; Crompton T; Adebayo J; Akpan F; Dauda DS; Allen Z; Ondura EO; Wose Kinge C; Chasela C; Pisa P
    BMJ Open; 2023 May; 13(5):e065950. PubMed ID: 37169497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with an interruption in treatment of people living with HIV in USAID-supported states in Nigeria: a retrospective study from 2000-2020.
    Tomescu S; Crompton T; Adebayo J; Kinge CW; Akpan F; Rennick M; Chasela C; Ondura E; Dauda DS; Pisa PT
    BMC Public Health; 2021 Nov; 21(1):2194. PubMed ID: 34847909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral load suppression after intensive adherence counselling among adult people living with HIV at Kiswa health centre, Kampala: a retrospective cohort study. Secondary data analysis.
    Nakaye C; Mukiza N; Mawanda D; Kataike H; Kaganzi H; Ahimbisibwe GM; Businge GB; Kyambadde RC; Nakalega R
    AIDS Res Ther; 2023 Mar; 20(1):18. PubMed ID: 36998004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in viral load suppression among HIV patients on antiretroviral therapy (ART) at Asante Mampong Municipal Hospital, Ghana: 2019-2023.
    Kyere GA; Vechey GA; Charles-Unadike VO; Tarkang EE
    BMC Infect Dis; 2024 Oct; 24(1):1170. PubMed ID: 39415134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the COVID-19 pandemic on HIV service delivery and viral suppression: Findings from the SHARP program in Northern Nigeria.
    Mugo C; Adedokun O; Alo OD; Ezeokafor N; Adeyemi S; Kpamor Z; Madueke L; James E; Adebajo SB; Semo BW
    PLoS One; 2024; 19(4):e0300335. PubMed ID: 38564514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018.
    Mhlanga TT; Jacobs BKM; Decroo T; Govere E; Bara H; Chonzi P; Sithole N; Apollo T; Van Damme W; Rusakaniko S; Lynen L; Makurumidze R
    AIDS Res Ther; 2022 Jul; 19(1):34. PubMed ID: 35810317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of viral load monitoring and viral suppression under Treat All in Rwanda - a cross-sectional study.
    Ross J; Ribakare M; Remera E; Murenzi G; Munyaneza A; Hoover DR; Shi Q; Nsanzimana S; Yotebieng M; Nash D; Anastos K;
    J Int AIDS Soc; 2020 Jun; 23(6):e25543. PubMed ID: 32536033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of point-of-care viral load testing to facilitate differentiated care: a qualitative assessment of people living with HIV and nurses in South Africa.
    Msimango L; Gibbs A; Shozi H; Ngobese H; Humphries H; Drain PK; Garrett N; Dorward J
    BMC Health Serv Res; 2020 Nov; 20(1):1081. PubMed ID: 33239012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral suppression among children and their caregivers living with HIV in western Kenya.
    Humphrey JM; Genberg BL; Keter A; Musick B; Apondi E; Gardner A; Hogan JW; Wools-Kaloustian K
    J Int AIDS Soc; 2019 Apr; 22(4):e25272. PubMed ID: 30983148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between low-level viraemia and subsequent viral non-suppression among people living with HIV/AIDS on antiretroviral therapy in Uganda.
    Nanyeenya N; Chang LW; Kiwanuka N; Nasuuna E; Nakanjako D; Nakigozi G; Kibira SPS; Nabadda S; Kiyaga C; Makumbi F
    PLoS One; 2023; 18(1):e0279479. PubMed ID: 36638086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of routine viral load testing among people living with HIV and its implementation challenges in Yangon region of Myanmar: a mixed-methods study.
    Thinn KK; Thekkur P; Kyaw NTT; Aye NS; Zaw TM; Soan P; Hone S; Oo HN
    BMJ Open; 2019 Dec; 9(12):e032678. PubMed ID: 31796489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
    Nakalega R; Mukiza N; Kiwanuka G; Makanga-Kakumba R; Menge R; Kataike H; Maena J; Akello C; Atuhaire P; Matovu-Kiweewa F; Ndikuno-Kuteesa C; Debem H; Mujugira A
    BMC Infect Dis; 2020 Oct; 20(1):727. PubMed ID: 33023498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania.
    Kahabuka MS; Woldeamanuel Y; Mbelele PM; Mpolya EA; Mpagama SG; Kessy JP; Manyazewal T
    BMC Infect Dis; 2024 Apr; 24(1):390. PubMed ID: 38605325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing multimonth dispensing of antiretrovirals and assessing the effect on viral load suppression among children and adolescents receiving HIV services in Nigeria.
    Casalini C; Bateganya M; Akolo C; Sanwo O; Idemudia A; Nwaokoro P; Eyam F; Ogbechie MD; Obiora-Okafo C; Oduola A; Wilcher R; Mack N; Khamofu H; Pandey SR
    PLoS One; 2023; 18(6):e0286303. PubMed ID: 37315075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues.
    Bvochora T; Satyanarayana S; Takarinda KC; Bara H; Chonzi P; Komtenza B; Duri C; Apollo T
    PLoS One; 2019; 14(2):e0211326. PubMed ID: 30721229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictors of unsuppressed viremia among PLHIV: a cross-sectional study in Ghana.
    Owusu LB; Ababio C; Boahene S; Zakaria AS; Emikpe AO; Dwumfour CK; Appiagyei KA; Apiribu F
    BMC Public Health; 2023 Jun; 23(1):1113. PubMed ID: 37296400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with HIV viral suppression among children and adults receiving antiretroviral therapy in Malawi in 2021: Evidence from the Laboratory Management Information System.
    Ng'ambi WF; Estill J; Jahn A; Orel E; Chimpandule T; Nyirenda R; Keiser O
    Trop Med Int Health; 2022 Jul; 27(7):639-646. PubMed ID: 35622358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to viral load testing guidelines, barriers, and associated factors among persons living with HIV on ART in Southwestern Uganda: a mixed-methods study.
    Lubega P; Nalugya SJ; Kimuli AN; Twinokusiima M; Khasalamwa M; Kyomugisa R; Kabami J; Owaraganise A
    BMC Public Health; 2022 Jun; 22(1):1268. PubMed ID: 35768800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unsuppressed viral load after intensive adherence counselling in rural eastern Uganda; a case of Kamuli district, Uganda.
    Ndikabona G; Alege JB; Kirirabwa NS; Kimuli D
    BMC Public Health; 2021 Dec; 21(1):2294. PubMed ID: 34922502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV Viral Suppression among People Living with HIV on Antiretroviral Therapy in Haut-Katanga and Kinshasa Provinces of Democratic Republic of Congo.
    Shah GH; Maluantesa L; Etheredge GD; Waterfield KC; Ikhile O; Beni R; Engetele E; Mulenga A
    Healthcare (Basel); 2021 Dec; 10(1):. PubMed ID: 35052234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.